You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美盈森(002303.SZ):子公司擬斥6000萬元建設CBD萃取項目
格隆匯 07-23 19:26

格隆匯 7 月 23日丨美盈森(002303.SZ)公佈,公司控股子公司暨美盈森集團工業大麻產業發展項目實施主體雲南文麻生物科技有限公司(“文麻生物”)與文山三七產業園區管理委員會於2020年7月22日完成了《投資協議》的簽署程序。為加快推進文山三七產業園區登高片區建設步伐,充分發揮合作優勢,實現雙方共同發展目標,文麻生物計劃投資6000萬元於文山三七產業園區登高片區建設工業大麻CBD萃取項目(“CBD萃取項目”)。CBD萃取項目為美盈森集團工業大麻產業發展項目項下的具體實施內容之一,此次投資無需另行履行審批程序。

項目名稱:雲南文麻生物科技有限公司工業大麻CBD萃取項目;項目建設地點:文山三七產業園區登高片區;項目建設單位:雲南文麻生物科技有限公司;項目投資概算:6000萬元;項目建設內容及用房安排:租賃三七園區4500平米標準廠房一棟,建設工業大麻CBD萃取生產線;項目開發建設週期:2年。

《投資協議》的簽訂,有利於落實CBD萃取項目的建設場地工作,有利於文麻生物工業大麻加工許可證的申請,有利於有序推動美盈森工業大麻產業發展項目的實施。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account